JT
Jasper Therapeutics, Inc.
SEC filingBiotechnology · Redwood City, CA
Amount raised$132Msold at filing
Total offering$132M
Investors in the raise40count reported to the SEC
FiledAug 5, 2026first sale Jul 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Herb CrossExecutive Officer
Gregory F. KeenanExecutive Officer
Thomas WiggansDirector
Jeet MahalExecutive Officer, Director
Svetlana LucasDirector
Kurt von EmsterDirector
Judith ShizuruDirector
Wenru SongExecutive Officer
Matthew E. RosDirector
Patrick CrutcherDirector
Executive officers, directors and promoters as listed on the Form D.